Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Biologic Products (now operating as Taibang Biologic Group) is a fully integrated, commercial-stage, plasma-based biopharmaceutical company in China that researches, develops, manufactures, and sells human plasma-derived and recombinant proteins such as albumin, immunoglobulins, and coagulation factors for a range of hematologic, immunologic, and critical care indications.[1][2][3][4][8][10][12]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Biologic Products.